SCHEMBL22354594

SCHEMBL22354594

CCCC(=O)OCCN(CCOC(=O)CC)CCN(CCOC(=O)CC)CCOC(=O)CCF

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 1/20 0.45
NAAA Q02083 1/20 0.41
ALDH1A1 P00352 3/20 0.39
CDYL Q9Y232 1/20 0.37
DGKA P23743 1/20 0.37
KDM4E B2RXH2 2/20 0.35
HTR2C P28335 1/20 0.34
GAA P10253 1/20 0.33
ADRA2A P08913 1/20 0.32
ADRA1A P35348 1/20 0.32
MAPT P10636 2/20 0.31
BLM P54132 1/20 0.31
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
CHRM5 P08912 1/20 0.31
CHRM1 P11229 1/20 0.31
CHRNB2 P17787 1/20 0.31
CHRM3 P20309 1/20 0.31
CHRNA4 P43681 1/20 0.31
THRB P10828 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25587779 0.86 DNM1 (0.52) DNM1NAAAALDH1A1CDYLDGKA
SCHEMBL65102 0.84 DNM1 (0.53) DNM1NAAAALDH1A1CDYLDGKA
Hydrochloric Acid SCHEMBL5845355 0.82 DNM1 (0.52) DNM1NAAAALDH1A1CDYLDGKA
SCHEMBL25587778 0.82 NAAA (0.50) DNM1NAAAALDH1A1CDYLDGKA
SCHEMBL11866866 0.81 DNM1 (0.50) DNM1NAAAALDH1A1CDYLDGKA
SCHEMBL64491 0.80 NAAA (0.52) DNM1NAAAALDH1A1CDYLDGKA
SCHEMBL11861419 0.79 NAAA (0.52) DNM1NAAAALDH1A1CDYLDGKA
SCHEMBL11856662 0.78 DNM1 (0.56) DNM1NAAAALDH1A1CDYLDGKA
Bromide SCHEMBL10618363 0.77 NAAA (0.50) DNM1NAAAALDH1A1CDYLDGKA
SCHEMBL11867827 0.77 CDYL (0.54) DNM1ALDH1A1CDYLDGKAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159581-A1 NOVEL ANTI-INFECTIVE AND ANTI-INFLAMMATORY COMPOUNDS SYNOVO GMBH (DE) 2023-05-25 US disclosed
US-20230131943-A1 ANTI-INFECTIVE AND ANTI-VIRAL COMPOUNDS AND COMPOSITIONS BURNET MICHEAL W (DE) 2023-04-27 US disclosed
US-20200262857-A1 NOVEL ANTI-INFECTIVE AND ANTI-INFLAMMATORY COMPOUNDS SYNOVO GMBH (DE) 2020-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230131943-A1 ANTI-INFECTIVE AND ANTI-VIRAL COMPOUNDS AND COMPOSITIONS CTSA, GAA, SLC7A5 DNM1 947/4885NAAA 323/4885ALDH1A1 3317/4885
US-20230159581-A1 NOVEL ANTI-INFECTIVE AND ANTI-INFLAMMATORY COMPOUNDS CTSA, ALOX15, ALOX5 DNM1 1164/4885NAAA 110/4885ALDH1A1 947/4885
US-20200262857-A1 NOVEL ANTI-INFECTIVE AND ANTI-INFLAMMATORY COMPOUNDS CTSA, ALOX15, ALOX5 DNM1 1164/4885NAAA 110/4885ALDH1A1 947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.